# Sang Hoon Ahn

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/sang-hoon-ahn/

## Facts

| Field | Value |
| --- | --- |
| Citations | 28,660 |
| Field | Liver Disease Diagnosis and Treatment |
| h-index | 75 |
| i10-index | 452 |
| Last Known Institution | Yonsei University |
| OpenAlex ID | https://openalex.org/A5006412769 |
| ORCID iD | https://orcid.org/0000-0002-3629-4624 |
| Works | 1,166 |

## Researcher papers

- [A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement](https://scholariq.org/papers/a-new-definition-for-metabolic-dysfunction-associated-fatty-liver-disease-an/)
- [The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease](https://scholariq.org/papers/the-asian-pacific-association-for-the-study-of-the-liver-clinical-practice/)
- [Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score](https://scholariq.org/papers/risk-estimation-for-hepatocellular-carcinoma-in-chronic-hepatitis-b-reach-b/)
- [Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients](https://scholariq.org/papers/validation-of-fib-4-and-comparison-with-other-simple-noninvasive-indices-for/)
- [Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)](https://scholariq.org/papers/pre-existing-liver-disease-is-associated-with-poor-outcome-in-patients-with-sars/)
- [A Liver Stiffness Measurement-Based, Noninvasive Prediction Model for High-Risk Esophageal Varices in B-Viral Liver Cirrhosis](https://scholariq.org/papers/a-liver-stiffness-measurement-based-noninvasive-prediction-model-for-high-risk/)
- [Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma](https://scholariq.org/papers/complete-response-at-first-chemoembolization-is-still-the-most-robust-predictor/)
- [A multicenter study of entecavir vs. tenofovir on prognosis of treatment-naïve chronic hepatitis B in South Korea](https://scholariq.org/papers/a-multicenter-study-of-entecavir-vs-tenofovir-on-prognosis-of-treatment-naive/)
- [Prediction of Development of Liver-Related Events by Transient Elastography in Hepatitis B Patients With Complete Virological Response on Antiviral Therapy](https://scholariq.org/papers/prediction-of-development-of-liver-related-events-by-transient-elastography-in/)
- [Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with transient elastography–defined subclinical cirrhosis](https://scholariq.org/papers/increased-risk-of-hepatocellular-carcinoma-in-chronic-hepatitis-b-patients-with/)
- [Persistent hepatitis B viral replication affects recurrence of hepatocellular carcinoma after curative resection](https://scholariq.org/papers/persistent-hepatitis-b-viral-replication-affects-recurrence-of-hepatocellular/)

## Researcher topics

- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Hepatitis B Virus Studies](https://scholariq.org/topics/hepatitis-b-virus-studies/)
- [Hepatitis C virus research](https://scholariq.org/topics/hepatitis-c-virus-research/)
- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Liver Disease and Transplantation](https://scholariq.org/topics/liver-disease-and-transplantation/)

## Researcher university

- [Yonsei University](https://scholariq.org/institutions/yonsei-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.